OmniAb (OABI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $4.59, -2.96% vs the prior close of $4.73.
- Volume 969.41K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
OABI dips 3.0% to $4.59. Closed at $4.59, -2.96% vs the prior close of $4.73. Day range $4.51–$4.82, opened at $4.73.
OABI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — OABI dips 3.0% to $4.59
- Closed at $4.59, -2.96% vs the prior close of $4.73. Day range $4.51–$4.82, opened at $4.73.
- Volume was 969.41K shares, 0.5x its 50-day average of 1.82M — lighter than usual.
- Price is +4.4% vs its 50-day average ($4.40) and +79.9% vs its 200-day average ($2.55).
- 52-week range $1.30–$5.43; today's close sits at 80% of that range, 15.5% below the 52-week high.
Oct 15, 2026 — OABI jumps 4.0% to $4.73
- Closed at $4.73, +3.96% vs the prior close of $4.55. Day range $4.53–$4.76, opened at $4.60.
- Volume was 820.50K shares, 0.5x its 50-day average of 1.82M — lighter than usual.
- Price is +8.8% vs its 50-day average ($4.35) and +86.4% vs its 200-day average ($2.54).
- 52-week range $1.30–$5.43; today's close sits at 83% of that range, 12.9% below the 52-week high.
Oct 14, 2026 — OABI slides 3.2% to $4.55, 3 down days in a row
- Closed at $4.55, -3.19% vs the prior close of $4.70. Day range $4.53–$4.83, opened at $4.62.
- Volume was 737.80K shares, 0.4x its 50-day average of 1.81M — lighter than usual.
- Price is +5.9% vs its 50-day average ($4.30) and +80.3% vs its 200-day average ($2.52).
- 52-week range $1.30–$5.43; today's close sits at 79% of that range, 16.2% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — OABI dips 1.5% to $4.70
- Closed at $4.70, -1.47% vs the prior close of $4.77. Day range $4.62–$4.82, opened at $4.76.
- Volume was 809.40K shares, 0.5x its 50-day average of 1.80M — lighter than usual.
- Price is +10.7% vs its 50-day average ($4.24) and +87.2% vs its 200-day average ($2.51).
- 52-week range $1.30–$5.43; today's close sits at 82% of that range, 13.4% below the 52-week high.
Oct 12, 2026 — OABI dips 0.4% to $4.77
- Closed at $4.77, -0.42% vs the prior close of $4.79. Day range $4.64–$4.84, opened at $4.77.
- Volume was 988.60K shares, 0.6x its 50-day average of 1.78M — lighter than usual.
- Price is +13.9% vs its 50-day average ($4.19) and +91.1% vs its 200-day average ($2.50).
- 52-week range $1.30–$5.43; today's close sits at 84% of that range, 12.2% below the 52-week high.
Oct 9, 2026 — OABI rises 2.8% to $4.79, 3 up days in a row
- Closed at $4.79, +2.79% vs the prior close of $4.66. Day range $4.59–$4.91, opened at $4.66.
- Volume was 1.04M shares, 0.6x its 50-day average of 1.77M — lighter than usual.
- Price is +15.9% vs its 50-day average ($4.13) and +93.0% vs its 200-day average ($2.48).
- 52-week range $1.30–$5.43; today's close sits at 85% of that range, 11.8% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — OABI rises 2.2% to $4.66
- Closed at $4.66, +2.19% vs the prior close of $4.56. Day range $4.22–$4.66, opened at $4.41.
- Volume was 1.53M shares, 0.9x its 50-day average of 1.74M.
- Price is +14.3% vs its 50-day average ($4.08) and +88.8% vs its 200-day average ($2.47).
- 52-week range $1.30–$5.43; today's close sits at 81% of that range, 14.2% below the 52-week high.
Oct 7, 2026 — OABI jumps 4.8% to $4.56
- Closed at $4.56, +4.83% vs the prior close of $4.35. Day range $4.30–$4.75, opened at $4.35.
- Volume was 1.50M shares, 0.9x its 50-day average of 1.72M.
- Price is +13.3% vs its 50-day average ($4.02) and +85.7% vs its 200-day average ($2.46).
- 52-week range $1.30–$5.43; today's close sits at 79% of that range, 16.0% below the 52-week high.
Oct 6, 2026 — OABI slides 11.6% to $4.35
- Closed at $4.35, -11.59% vs the prior close of $4.92. Day range $4.22–$5.00, opened at $4.85.
- Volume was 2.00M shares, 1.2x its 50-day average of 1.68M.
- Price is +9.5% vs its 50-day average ($3.97) and +78.1% vs its 200-day average ($2.44).
- 52-week range $1.30–$5.43; today's close sits at 74% of that range, 19.9% below the 52-week high.
Oct 5, 2026 — OABI rises 1.0% to $4.92
- Closed at $4.92, +1.03% vs the prior close of $4.87. Day range $4.64–$5.02, opened at $4.83.
- Volume was 1.22M shares, 0.7x its 50-day average of 1.66M.
- Price is +25.3% vs its 50-day average ($3.93) and +102.3% vs its 200-day average ($2.43).
- 52-week range $1.30–$5.43; today's close sits at 88% of that range, 9.4% below the 52-week high.
Oct 2, 2026 — OABI dips 2.4% to $4.87
- Closed at $4.87, -2.40% vs the prior close of $4.99. Day range $4.81–$5.09, opened at $5.04.
- Volume was 1.62M shares, 1.0x its 50-day average of 1.64M.
- Price is +25.9% vs its 50-day average ($3.87) and +101.5% vs its 200-day average ($2.42).
- 52-week range $1.30–$5.43; today's close sits at 86% of that range, 10.3% below the 52-week high.
OABI latest news & SEC filings
Every SEC filing by or about OABI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $13.41M (prior year $3.90M) (+244.2% vs Jun 30, 2025)
- Net income: -$5.86M (prior year -$15.88M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.05 (prior year -$0.15) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 13, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade OABI
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 4, 2026, Nov 4, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.06% (largest 11.6%). That is a volatile stock.
- Liquidity: about 1.24M shares (≈$5.70M) trade per day on average.
- 52-week position: $4.59 vs a range of $1.30–$5.43 (80% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Charles S Berkman sold 7,157 shares on Apr 7, 2026.
- Latest filings: 10-Q Aug 6, 2026; 8-K Aug 6, 2026; 8-K Jul 13, 2026.
- Share count: 145.39M shares outstanding (Jul 30, 2026), +18.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Commercial Physical & Biological Research.
OABI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.73 | 4.82 | 4.51 | 4.59 | 969.41K |
| Oct 15, 2026 | 4.60 | 4.76 | 4.53 | 4.73 | 820.50K |
| Oct 14, 2026 | 4.62 | 4.83 | 4.53 | 4.55 | 737.80K |
| Oct 13, 2026 | 4.76 | 4.82 | 4.62 | 4.70 | 809.40K |
| Oct 12, 2026 | 4.77 | 4.84 | 4.64 | 4.77 | 988.60K |
| Oct 9, 2026 | 4.66 | 4.91 | 4.59 | 4.79 | 1.04M |
| Oct 8, 2026 | 4.41 | 4.66 | 4.22 | 4.66 | 1.53M |
| Oct 7, 2026 | 4.35 | 4.75 | 4.30 | 4.56 | 1.50M |
| Oct 6, 2026 | 4.85 | 5.00 | 4.22 | 4.35 | 2.00M |
| Oct 5, 2026 | 4.83 | 5.02 | 4.64 | 4.92 | 1.22M |
| Oct 2, 2026 | 5.04 | 5.09 | 4.81 | 4.87 | 1.62M |
| Oct 1, 2026 | 4.94 | 5.05 | 4.84 | 4.99 | 1.98M |
| Sep 30, 2026 | 4.76 | 5.05 | 4.72 | 4.96 | 1.93M |
| Sep 29, 2026 | 4.74 | 4.95 | 4.61 | 4.74 | 1.39M |
| Sep 28, 2026 | 4.61 | 4.81 | 4.55 | 4.74 | 674.90K |
| Sep 25, 2026 | 4.82 | 4.84 | 4.59 | 4.61 | 783.60K |
| Sep 24, 2026 | 4.75 | 4.86 | 4.63 | 4.79 | 1.04M |
| Sep 23, 2026 | 4.90 | 4.99 | 4.68 | 4.79 | 1.05M |
| Sep 22, 2026 | 4.61 | 4.93 | 4.55 | 4.92 | 1.38M |
| Sep 21, 2026 | 4.50 | 4.64 | 4.45 | 4.58 | 1.36M |
About OmniAb
OmniAb (OABI) is listed on the Nasdaq and classified by the SEC under “Services-Commercial Physical & Biological Research”. Its business address is in EMERYVILLE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1846253.
OABI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Carolyn R Bertozzi | Director | Jun 18, 2026 |
| Jennifer R. Cochran | Director | Jun 18, 2026 |
| Steven C. Crouse | Director | Jun 18, 2026 |
| Matthew W Foehr | President and CEO | Apr 7, 2026 |
| Philip J Gotwals | Director | Jun 18, 2026 |
| John L Higgins | Director | Jun 18, 2026 |
| Steven Love | Director | Jun 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Charles S Berkman | Chief Legal Officer | Apr 7, 2026 |
| Matthew W Foehr | President and CEO | Apr 7, 2026 |
| Kurt A Gustafson | Executive VP, Finance and CFO | Apr 7, 2026 |
| Amechi Ekeke Nwachuku | Chief Operating Officer | Aug 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Apr 7, 2026 | Charles S Berkman | Sale | 7,157 | $1.49 |
| Apr 7, 2026 | Charles S Berkman | Sale | 7,157 | $1.49 |
| Apr 7, 2026 | Charles S Berkman | Sale | 7,157 | $1.49 |
| Apr 7, 2026 | Charles S Berkman | Sale | 7,157 | $1.49 |
| Apr 7, 2026 | Kurt A Gustafson | Sale | 6,913 | $1.49 |
| Apr 7, 2026 | Kurt A Gustafson | Sale | 6,913 | $1.49 |
| Apr 7, 2026 | Kurt A Gustafson | Sale | 6,913 | $1.49 |
| Apr 7, 2026 | Kurt A Gustafson | Sale | 6,913 | $1.49 |
| Apr 7, 2026 | Matthew W Foehr | Sale | 19,244 | $1.49 |
| Apr 7, 2026 | Matthew W Foehr | Sale | 19,244 | $1.49 |
| Apr 7, 2026 | Matthew W Foehr | Sale | 19,244 | $1.49 |
| Apr 7, 2026 | Matthew W Foehr | Sale | 19,244 | $1.49 |
| Feb 18, 2026 | Charles S Berkman | Sale | 9,673 | $1.71 |
| Feb 18, 2026 | Charles S Berkman | Sale | 9,673 | $1.71 |
| Feb 18, 2026 | Charles S Berkman | Sale | 9,673 | $1.71 |
OABI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $18.67M | $-64.78M | -0.57 | $-36.45M |
| Dec 31, 2024 | $26.39M | $-62.03M | -0.61 | $-39.66M |
| Dec 31, 2023 | $34.16M | $-50.62M | -0.51 | $2.35M |
| Dec 31, 2022 | $59.08M | $-22.33M | -0.26 | $-3.59M |
| Dec 31, 2021 | $34.75M | $-27.04M | -0.33 | $-5.67M |
Latest balance sheet: total assets $290.26M, total liabilities $29.98M, cash $24.34M (as of Jun 30, 2026).
OABI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $2.24 |
| May 7, 2026 | 8-K Item 2.02 (results) | $1.47 |
| Mar 4, 2026 | 8-K Item 2.02 (results) | $1.81 |
| Nov 4, 2025 | 8-K Item 2.02 (results) | $1.48 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $1.93 |
| May 8, 2025 | 8-K Item 2.02 (results) | $1.57 |
| Mar 18, 2025 | 8-K Item 2.02 (results) | $3.19 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $4.49 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 20, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Commercial Physical & Biological Research
Iqvia (IQV)Charles River Laboratories International (CRL)Incyte (INCY)Icon (ICLR)Medpace (MEDP)Absci (ABSI)bioAffinity Technologies (BIAF)Nrc Health (NRC)Maxcyte (MXCT)iSpecimen (ISPC)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on OABI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.